One of the missions of NewG Lab Pharma
(NGLP) will be to develop novel anticancer
therapeutics that extend the life of cancer patients
without compromising the quality of life.
Yvar Verhoeven presentation 13112009 at Johns Hopkins.
- Yvar
Verhoeven meets students after his presentation at John's Hopkins, November
13th, 2009.
- The
first patient to be treated with Dr. Ko's 3BP compound.
- A Translational Study "Case Report" on the Small Molecule "Energy Blocker" 3-Bromopyruvate (3BP)
as a Potent Anticancer Agent: From Bench
Side to Bedside(2012)
https://www.youtube.com/watch?v=Jm7f5FOWqvI&feature=youtu.be
(part 1)
https://www.youtube.com/watch?v=aOszMBpMK9s
(part 2)
https://www.youtube.com/watch?v=aOszMBpMK9s&feature=youtu.be
(part 3)
https://www.youtube.com/watch?v=DF3Uvo9mnPM&feature=youtu.be
(part 5)